Healthways shares declined 5 percent on nearly twice the average daily volume Tuesday after Citigroup analysts initiated coverage on the company with a “sell” rating and a $9 price target.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.